The predictive models were significantly better (p < 0.01) than ABTpeak, ABTcum and ALT individually for the prediction of NASH and definite NASH, but not significantly better than USS (p > 0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.